262 related articles for article (PubMed ID: 31660682)
1. Early clinical experience with varian halcyon V2 linear accelerator: Dual-isocenter IMRT planning and delivery with portal dosimetry for gynecological cancer treatments.
Kim H; Huq MS; Lalonde R; Houser CJ; Beriwal S; Heron DE
J Appl Clin Med Phys; 2019 Nov; 20(11):111-120. PubMed ID: 31660682
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sliding window and field-in-field techniques for tangential whole breast irradiation using the Halcyon and Synergy Agility systems.
Richter A; Wegener S; Breuer K; Razinskas G; Weick S; Exner F; Bratengeier K; Flentje M; Sauer O; Polat B
Radiat Oncol; 2021 Nov; 16(1):213. PubMed ID: 34742291
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry study of nasopharyngeal carcinoma based on Halcyon accelerator fixed-field intensity-modulated radiation therapy.
Li K; Li C; Zhu T; Chen J; Cao W; Yin Y; Ma C
J Cancer Res Ther; 2021 Nov; 17(5):1165-1171. PubMed ID: 34850763
[TBL] [Abstract][Full Text] [Related]
4. Interplay effect on a 6-MV flattening-filter-free linear accelerator with high dose rate and fast multi-leaf collimator motion treating breast and lung phantoms.
Netherton T; Li Y; Nitsch P; Shaitelman S; Balter P; Gao S; Klopp A; Muruganandham M; Court L
Med Phys; 2018 Jun; 45(6):2369-2376. PubMed ID: 29611210
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric impact and detectability of multi-leaf collimator positioning errors on Varian Halcyon.
Gay SS; Netherton TJ; Cardenas CE; Ger RB; Balter PA; Dong L; Mihailidis D; Court LE
J Appl Clin Med Phys; 2019 Aug; 20(8):47-55. PubMed ID: 31294923
[TBL] [Abstract][Full Text] [Related]
6. Single isocenter versus dual isocenter treatment using flattening filter-free and jaw-tracking volumetrically modulated arc therapy for boot-shaped lung cancer: Evaluation of dosimetric and feasibility.
Zhang L; Cheng H; Du F; Shao K; Zheng S; Yang Y; Shan G
J Appl Clin Med Phys; 2024 Jun; 25(6):e14292. PubMed ID: 38286001
[TBL] [Abstract][Full Text] [Related]
7. SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring-mounted Halcyon Linac.
Pokhrel D; Webster A; Stephen J; St Clair W
J Appl Clin Med Phys; 2021 Jun; 22(6):162-171. PubMed ID: 34032367
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiotherapy of intracranial tumor beds on a ring-mounted Halcyon LINAC.
Misa J; McCarthy S; Clair WS; Pokhrel D
J Appl Clin Med Phys; 2024 Jun; 25(6):e14281. PubMed ID: 38277473
[TBL] [Abstract][Full Text] [Related]
9. Double-vertebral segment SBRT via novel ring-mounted Halcyon Linac: Plan quality, delivery efficiency and accuracy.
Pokhrel D; Stephen J; Webster A; Bernard ME
Med Dosim; 2022 Spring; 47(1):20-25. PubMed ID: 34412963
[TBL] [Abstract][Full Text] [Related]
10. Practical approach for pretreatment verification of IMRT with flattening filter free(FFF) beams using Varian Portal Dosimetry.
Min S; Choi YE; Kwak J; Cho B
J Appl Clin Med Phys; 2014 Jan; 16(1):4934. PubMed ID: 25679149
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
[TBL] [Abstract][Full Text] [Related]
12. Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer.
Sun T; Lin X; Zhang G; Qiu Q; Li C; Yin Y
Radiat Oncol; 2021 Feb; 16(1):35. PubMed ID: 33602267
[TBL] [Abstract][Full Text] [Related]
13. Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancer.
Bedford JL; Smyth G; Hanson IM; Tree AC; Dearnaley DP; Hansen VN
Radiother Oncol; 2016 Aug; 120(2):320-6. PubMed ID: 27470308
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of interfraction setup variations for postmastectomy radiation therapy using EPID-based in vivo dosimetry.
Kang S; Li J; Ma J; Zhang W; Liao X; Qing H; Tan T; Xin X; Tang B; Piermattei A; Orlandini LC
J Appl Clin Med Phys; 2019 Oct; 20(10):43-52. PubMed ID: 31541537
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms.
Laugeman E; Heermann A; Hilliard J; Watts M; Roberson M; Morris R; Goddu S; Sethi A; Zoberi I; Kim H; Mutic S; Hugo G; Cai B
J Appl Clin Med Phys; 2020 Jul; 21(7):39-48. PubMed ID: 32368862
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment plans for hypofractionated high-dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms.
Tamihardja J; Razinskas G; Exner F; Richter A; Kessler P; Weick S; Kraft J; Mantel F; Flentje M; Polat B
J Appl Clin Med Phys; 2021 Sep; 22(9):262-270. PubMed ID: 34351055
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Evaluation of the Application of the Halcyon(2.0) IMRT Technique in Long-Course Radiotherapy for Rectal Cancer.
Zheng J; Xia Y; Sun L
Technol Cancer Res Treat; 2022; 21():15330338221074501. PubMed ID: 35235486
[No Abstract] [Full Text] [Related]
18. The delivery assessment for small targets on Halcyon radiotherapy system - Measured and calculated dose comparison.
Lankinen L; Kulmala A; Lehtomäki J; Harju A
J Appl Clin Med Phys; 2024 Jun; 25(6):e14407. PubMed ID: 38775807
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study.
Dobler B; Obermeier T; Hautmann MG; Khemissi A; Koelbl O
Radiat Oncol; 2017 Jul; 12(1):114. PubMed ID: 28679448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]